In-Depth Cell-Type-Specific Proteome Landscape of the Brain from Human Amyloid-β Overexpression Mouse Model
Taekyung Ryu1,2, Seok-Young Kim1,2, Thujitha Thuraisamy1,2
1Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD, 21205, USA.
Summary
This study introduces a novel method, in situ cell-type-specific proteome analysis using antibody-mediated biotinylation (iCAB), to analyze brain cell proteomes in Alzheimer's disease models. iCAB reveals cell-specific protein changes, offering new insights into disease mechanisms.
Area of Science:
- Neuroscience
- Proteomics
- Biochemistry
Background:
- Alzheimer's disease (AD) pathogenesis involves Amyloid-β (Aβ) overexpression.
- Studying cell-type-specific proteome alterations in the brain is crucial but difficult due to tissue complexity.
- Existing methods for cell-specific proteomics have limitations, including genetic modification requirements or complex isolation procedures.
Purpose of the Study:
- To develop and validate a novel method for in situ cell-type-specific proteome analysis.
- To investigate the cell-type-specific proteome landscape in a mouse model of Aβ overexpression relevant to AD.
- To identify unique molecular pathways altered in different brain cell types during Aβ pathology.
Main Methods:
- Introduced in situ cell-type-specific proteome analysis using antibody-mediated biotinylation (iCAB).
- Applied iCAB using immunohistochemistry with biotin-tyramide to target cell-specific proteins directly within intact tissue.
- Utilized the 5xFAD mouse model, a relevant model for human Aβ overexpression in AD.
Main Results:
- Successfully identified approximately 8000 cell-type-specific proteomes.
- Demonstrated significantly more differentially expressed proteins compared to traditional bulk proteome methods.
- Pinpointed distinct cellular pathways: mRNA processing in neurons, calcium regulation in astrocytes, and phagocytosis in microglia.
Conclusions:
- iCAB is a powerful, straightforward tool for cell-type-specific proteome analysis in brain tissue.
- The method is applicable to both animal models and human tissues without genetic modification.
- Provides the first in-depth, cell-type-specific brain proteome landscape of an Aβ overexpression model, offering novel insights into AD pathogenesis.
